INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

24,511 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$320K
11.5K sh
Sep 2, 2026Sep 3, 2026
Page 165 of 613
← PrevNext →
traded Sep 2, 2026
+1d
SEC Form 4

Evidence

20
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,000 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

19
FJ
Fego Paul JSVP, Global Operations
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$240K
2,400 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

19
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Open-market sale · 10b5-1 plan
SELL$220K
13.2K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

19
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
5,439 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

19
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$1.42M
13.3K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

18
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$222K
34.1K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

17
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$113K
4,075 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$4.96M
15.2K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

16
FJ
Fego Paul JSVP, Global Operations
QRVOQorvo, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
100 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

15
GK
Guarini KathrynDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$340K
400 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

14
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$821K
19.3K sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$8,177
3,618 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$4,793
2,121 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$275K
6,348 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$13K
5,863 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$746K
17.4K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

14
RS
Radhakrishnan SrikanthChief Science & Techn. Officer
LUNGPulmonx Corp
Open-market sale
SELL$5,973
2,643 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$54.02
2 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

13
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$36K
15.0K sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

13
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
6,862 sh
Aug 28, 2026Sep 3, 2026
traded Aug 28, 2026
+6dSEC Form 4

Evidence

12
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$767K
7,215 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

11
BC
Barrett CherieSVP, Chief Accounting Officer
DOCNDigitalOcean Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$421K
3,985 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

10
HJ
Hawkins Matthew J.Director, Chief Executive Officer
WAYWaystar Holding Corp.
Open-market sale · 10b5-1 plan
SELL$2.14M
82.5K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

10
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$109K
1,344 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

10
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$89K
1,090 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

9
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$449K
1,400 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$320K
1,000 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

9
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$965K
22.8K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
RS
Randhawa SimratEVP, Head of R&D
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$273K
2,600 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

8
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
858 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

7
CE
Colburn Richard Edward IIIChief Product & Tech Officer
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$40K
479 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

7
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
1,833 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

7
VN
Viljoen NataschaDirector, President & CEO
NEMNEWMONT Corp /DE/
Open-market sale · 10b5-1 plan
SELL$477K
3,882 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
1,368 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

6
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
600 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

3
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$392
94 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

3
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$142
34 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

1
AT
Arora TarunChief Accounting Officer
RNGRingCentral, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
954 sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC Form 4

Evidence

46
YM
Yurcisin Jeffrey MichaelDirector, President & CEO
GROVGrove Collaborative Holdings, Inc.
Open-market purchase
BUY$95K
90.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence